𝗪𝗵𝗼 𝗶𝘀 𝗕𝗶𝗼𝗠𝗼𝗱𝗲𝗹𝘀?

𝗜𝗻 𝘀𝗵𝗼𝗿𝘁: 𝗪𝗵𝗼 𝗶𝘀 𝗕𝗶𝗼𝗠𝗼𝗱𝗲𝗹𝘀, 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝗱𝗼 𝘄𝗲 𝗱𝗼?
We’re a Boston-based preclinical CRO that helps biotechnology and pharmaceutical companies answer one critical question before moving into the clinic:

𝗗𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗼𝗿𝗸, 𝗮𝗻𝗱 𝗶𝘀 𝗶𝘁 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝗺𝗼𝘃𝗲 𝘁𝗼𝘄𝗮𝗿𝗱 𝘁𝗵𝗲 𝗰𝗹𝗶𝗻𝗶𝗰?
We design and execute predictive, translational, non-GLP efficacy studies in mice, rats, hamsters, and guinea pigs, partnering with clients from early discovery through IND-enabling research.

𝗢𝘂𝗿 𝗮𝗿𝗲𝗮𝘀 𝗼𝗳 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:
🧬 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 & 𝗔𝘂𝘁𝗼𝗶𝗺𝗺𝘂𝗻𝗲: IBD/colitis (DSS, TNBS, T-cell transfer), arthritis (CIA, CAIA), GVHD, dermatitis, asthma (OVA, HDM), EoE
🫁 𝗙𝗶𝗯𝗿𝗼𝘀𝗶𝘀: IPF (bleomycin), liver (CCl₄), scleroderma
☢️ 𝗥𝗮𝗱𝗶𝗮𝘁𝗶𝗼𝗻: GI-ARS, TBI, fibrosis, mucositis, proctitis
⚖️ 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰: Diet-induced obesity (DIO), MASH/NASH, diabetes, wound healing
🎗️ 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆: Xenograft, syngeneic, orthotopic, actinic keratosis, polyposis
🧠 𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲: Behavior, addiction, autism, Parkinson’s, pain
🌬️ 𝗣𝘂𝗹𝗺𝗼𝗻𝗮𝗿𝘆: Acute lung injury (LPS), asthma, inhalation
🦠 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: Germ-free, gnotobiotic, infectious disease
🔬 𝗖𝘂𝘀𝘁𝗼𝗺 𝗠𝗼𝗱𝗲𝗹 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: Surgical models, manuscript replication
🧪 𝗜𝗻 𝗩𝗶𝘁𝗿𝗼/𝗘𝘅 𝗩𝗶𝘃𝗼 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: Cell culture, flow cytometry, Luminex, ELISA, qRT-PCR, microbiology

Whether you’re evaluating efficacy, optimizing study design, or developing a custom model, our team is here to help generate the data you need to move your program forward.

Back to All News